We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current CYTH market cap is 20.14M. The company's latest EPS is USD -0.6972 and P/E is -0.99.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 495k | 311k | 202k | 124k | 233k |
| Operating Income | -4.77M | -5.64M | -5.11M | -5.64M | -8.29M |
| Net Income | -4.77M | -5.64M | -4.34M | -5.98M | -8.83M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 1.01M | 903k | 1.59M | 1.38M | 1.08M |
| Operating Income | -7.39M | -8.96M | -14.27M | -15.62M | -20.05M |
| Net Income | -7.53M | -8.94M | -14.29M | -15.45M | -20.06M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 5.6M | 13.25M | 7.16M | 4.72M | 5.25M |
| Total Liabilities | 6.65M | 8.49M | 6.55M | 9.84M | 18.73M |
| Total Equity | -1.05M | 4.76M | 610k | -5.12M | -13.47M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 4.11M | 14.19M | 19.52M | 4.22M | 13.25M |
| Total Liabilities | 3.18M | 3.74M | 3.85M | 3.48M | 8.49M |
| Total Equity | 936k | 10.45M | 15.67M | 734k | 4.76M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -11.89M | -16.18M | -6.18M | -10.03M | -18.22M |
| Investing | N/A | -2k | N/A | N/A | N/A |
| Financing | 12.15M | 23.89M | -69k | 1.91M | 9.9M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -6.59M | -8.54M | -15.01M | -15.12M | -16.18M |
| Investing | 36k | -14k | 14k | 38k | -2k |
| Financing | 7.12M | 18.62M | 18.76M | 7k | 23.89M |
| Market Cap | 20.14M |
| Price to Earnings Ratio | -0.99 |
| Price to Sales Ratio | 18.45 |
| Price to Cash Ratio | 2.15 |
| Price to Book Ratio | 4.17 |
| Dividend Yield | - |
| Shares Outstanding | 28.77M |
| Average Volume (1 week) | 48.14k |
| Average Volume (1 Month) | 63.58k |
| 52 Week Change | -50.70% |
| 52 Week High | 1.79 |
| 52 Week Low | 0.55 |
| Spread (Intraday) | 0.09 (12.04%) |
| Company Name | Cyclo Therapeutics Inc |
| Address |
6714 nw 16th street gainesville, florida 32653 |
| Website | https://www.cyclotherapeutics.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
